Delivery Order SPE2DB22D1103-SPE2DB24FTRJ7
Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $3,018.80 firm fixed-price delivery order is for the supply of CANDIN SKIN TESTML products. The contract does not have a set-aside designation and has an ultimate completion date of August 13, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,970.40 firm fixed-price delivery order is for "CANDIN SKIN TESTML" medical supplies, with a period of performance through January 29, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,284.00, is for the delivery of CANDIN SKIN TESTML, a medical product, with a period of performance through April 28, 2025. The contract is a Delivery Order and is priced on a Firm Fixed Price basis. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,076.55 firm fixed-price delivery order covers the supply of CANDIN SKIN TESTML, a medical product, with a period of performance through September 21, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, valued at $1,811.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of "CANDIN SKIN TESTML" medical products. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,387.20 firm fixed-price delivery order (SPE2DB20D3101|SPE2DB24FQUJ3) is for Candin Skin Test ML medical products, with a period of performance through November 13, 2023. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop...
- This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,970.40, is for the delivery of Candin Skin Test supplies. The contract is a Firm Fixed Price arrangement with a performance period extending to July 14, 2025. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not set aside for any specific business...
- This federal contract award, identified as SPE2DX15D1022|SPE2DX25FVEXR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of "CANDIN SKIN TESTML" medical supplies, with a ceiling value of $4,926.00 and a completion date of May 8, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition....
- This federal contract award, worth $97,586.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,846.99, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc. The IDC, worth up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTRJ7Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,912.27, is for the delivery of "CANDIN SKIN TESTML" medical supplies. This is a Firm Fixed Price Delivery Order contract with a completion date of September 13, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, such as the Department of Justice Federal Bureau of Investigation, for the supply of a wide range of pharmaceutical and medical products to support military treatment programs, veterans' healthcare, and other federal healthcare needs.
Generated 12/12/24, 10:13 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/12/24 |